Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain, Postoperative | 6 | 2018 | 175 | 1.860 |
Why?
|
| Spinal Cord | 11 | 2018 | 139 | 1.380 |
Why?
|
| Hyperalgesia | 6 | 2018 | 88 | 0.900 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2018 | 748 | 0.860 |
Why?
|
| Rats | 16 | 2018 | 1609 | 0.820 |
Why?
|
| Paclitaxel | 4 | 2020 | 51 | 0.690 |
Why?
|
| TRPV Cation Channels | 2 | 2016 | 19 | 0.670 |
Why?
|
| Neuroglia | 3 | 2015 | 29 | 0.670 |
Why?
|
| Spinal Nerves | 4 | 2018 | 65 | 0.660 |
Why?
|
| Recovery of Function | 3 | 2018 | 190 | 0.650 |
Why?
|
| Pain | 9 | 2016 | 285 | 0.650 |
Why?
|
| Analgesia | 2 | 2015 | 33 | 0.630 |
Why?
|
| Animals | 28 | 2018 | 7339 | 0.630 |
Why?
|
| Ganglia, Spinal | 6 | 2017 | 63 | 0.620 |
Why?
|
| Neurons, Afferent | 4 | 2006 | 54 | 0.610 |
Why?
|
| Stress, Psychological | 1 | 2018 | 210 | 0.550 |
Why?
|
| Signal Transduction | 2 | 2018 | 674 | 0.530 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2015 | 32 | 0.530 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2020 | 46 | 0.510 |
Why?
|
| Capsaicin | 2 | 2014 | 30 | 0.490 |
Why?
|
| Anesthetics, Combined | 1 | 2014 | 5 | 0.480 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2014 | 5 | 0.480 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 17 | 0.480 |
Why?
|
| Lidocaine | 1 | 2014 | 17 | 0.480 |
Why?
|
| Bone Neoplasms | 4 | 2016 | 105 | 0.460 |
Why?
|
| Nerve Block | 1 | 2014 | 48 | 0.460 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2007 | 38 | 0.430 |
Why?
|
| Pain Measurement | 5 | 2015 | 365 | 0.410 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 984 | 0.400 |
Why?
|
| Male | 26 | 2018 | 18012 | 0.390 |
Why?
|
| Ondansetron | 1 | 2010 | 5 | 0.370 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2010 | 20 | 0.370 |
Why?
|
| Amines | 1 | 2010 | 22 | 0.370 |
Why?
|
| Analgesics | 2 | 2011 | 126 | 0.360 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 47 | 0.360 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 74 | 0.360 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 75 | 0.340 |
Why?
|
| Macrophages | 2 | 2007 | 188 | 0.320 |
Why?
|
| Sciatic Nerve | 1 | 2007 | 35 | 0.300 |
Why?
|
| Sensory Receptor Cells | 2 | 2017 | 29 | 0.290 |
Why?
|
| Peripheral Nerves | 2 | 2006 | 59 | 0.280 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 18 | 0.280 |
Why?
|
| Receptors, Endothelin | 2 | 2003 | 4 | 0.280 |
Why?
|
| Neural Conduction | 3 | 2020 | 82 | 0.280 |
Why?
|
| Tibial Nerve | 2 | 2020 | 17 | 0.270 |
Why?
|
| Behavior, Animal | 4 | 2015 | 264 | 0.260 |
Why?
|
| Polyneuropathies | 1 | 2005 | 10 | 0.260 |
Why?
|
| Spinal Cord Ischemia | 1 | 2003 | 2 | 0.220 |
Why?
|
| Gliosis | 1 | 2003 | 4 | 0.220 |
Why?
|
| Physical Stimulation | 3 | 2014 | 84 | 0.220 |
Why?
|
| Glial Fibrillary Acidic Protein | 5 | 2014 | 37 | 0.220 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 32 | 0.220 |
Why?
|
| Nociceptors | 3 | 2014 | 41 | 0.190 |
Why?
|
| Time Factors | 5 | 2015 | 2014 | 0.190 |
Why?
|
| Dependovirus | 2 | 2017 | 18 | 0.180 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 4 | 2007 | 22 | 0.180 |
Why?
|
| Nerve Fibers | 3 | 2020 | 31 | 0.180 |
Why?
|
| Activating Transcription Factor 3 | 4 | 2007 | 6 | 0.180 |
Why?
|
| Taxoids | 1 | 2020 | 48 | 0.180 |
Why?
|
| Sural Nerve | 1 | 2020 | 23 | 0.180 |
Why?
|
| Antigens, CD | 4 | 2007 | 100 | 0.180 |
Why?
|
| Median Nerve | 1 | 2020 | 45 | 0.170 |
Why?
|
| Injections, Spinal | 4 | 2018 | 124 | 0.170 |
Why?
|
| RNA, Messenger | 2 | 2018 | 523 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 1389 | 0.160 |
Why?
|
| Receptors, Vasopressin | 1 | 2018 | 7 | 0.160 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 8 | 0.160 |
Why?
|
| Psychology | 1 | 2018 | 22 | 0.160 |
Why?
|
| Pruritus | 2 | 2015 | 58 | 0.160 |
Why?
|
| Oxytocin | 2 | 2018 | 22 | 0.160 |
Why?
|
| Thalamus | 1 | 2018 | 39 | 0.160 |
Why?
|
| Up-Regulation | 2 | 2016 | 183 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 101 | 0.150 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 70 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 118 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2020 | 350 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2017 | 88 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2017 | 119 | 0.150 |
Why?
|
| Femoral Fractures | 2 | 2007 | 39 | 0.150 |
Why?
|
| Nerve Growth Factor | 2 | 2007 | 4 | 0.140 |
Why?
|
| Chemokines | 1 | 2016 | 35 | 0.140 |
Why?
|
| Receptors, Opioid | 1 | 2016 | 38 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2016 | 143 | 0.140 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2015 | 2 | 0.140 |
Why?
|
| Receptors, Bombesin | 1 | 2015 | 8 | 0.130 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2015 | 7 | 0.130 |
Why?
|
| Arvicolinae | 1 | 2015 | 2 | 0.130 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2015 | 24 | 0.130 |
Why?
|
| Ligation | 2 | 2018 | 55 | 0.130 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 16 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 59 | 0.130 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2015 | 40 | 0.130 |
Why?
|
| Mice, Inbred C3H | 5 | 2007 | 23 | 0.130 |
Why?
|
| Pyramidal Tracts | 1 | 2015 | 3 | 0.130 |
Why?
|
| Imidazoles | 1 | 2015 | 104 | 0.130 |
Why?
|
| Receptors, Opioid, mu | 1 | 2015 | 51 | 0.130 |
Why?
|
| Glutamic Acid | 1 | 2015 | 46 | 0.130 |
Why?
|
| Astrocytes | 2 | 2007 | 49 | 0.130 |
Why?
|
| Neuralgia | 1 | 2015 | 48 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 548 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 2 | 2007 | 198 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2015 | 167 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 31 | 0.120 |
Why?
|
| Sensory System Agents | 1 | 2014 | 7 | 0.120 |
Why?
|
| Oxytocics | 1 | 2014 | 11 | 0.120 |
Why?
|
| Mechanoreceptors | 1 | 2014 | 37 | 0.120 |
Why?
|
| Mice | 7 | 2015 | 2387 | 0.120 |
Why?
|
| Nerve Growth Factors | 2 | 2018 | 18 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 680 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 484 | 0.110 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 77 | 0.110 |
Why?
|
| Inflammation | 1 | 2016 | 511 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 796 | 0.110 |
Why?
|
| Microglia | 2 | 2016 | 48 | 0.100 |
Why?
|
| Norepinephrine | 1 | 2011 | 74 | 0.100 |
Why?
|
| Quinolizines | 1 | 2010 | 2 | 0.090 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 5 | 0.090 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2010 | 3 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2010 | 26 | 0.090 |
Why?
|
| Female | 8 | 2020 | 18379 | 0.090 |
Why?
|
| Indoles | 1 | 2010 | 59 | 0.090 |
Why?
|
| Hindlimb | 1 | 2010 | 57 | 0.090 |
Why?
|
| Injections, Intravenous | 2 | 2006 | 73 | 0.090 |
Why?
|
| Posterior Horn Cells | 2 | 2006 | 11 | 0.080 |
Why?
|
| Brain | 1 | 2015 | 933 | 0.080 |
Why?
|
| Injections, Intraventricular | 1 | 2007 | 16 | 0.080 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 11 | 0.080 |
Why?
|
| Cell Size | 1 | 2007 | 35 | 0.080 |
Why?
|
| Sarcoma | 2 | 2005 | 56 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 129 | 0.070 |
Why?
|
| Satellite Cells, Perineuronal | 1 | 2006 | 1 | 0.070 |
Why?
|
| Schwann Cells | 1 | 2006 | 5 | 0.070 |
Why?
|
| Trigeminal Ganglion | 1 | 2006 | 1 | 0.070 |
Why?
|
| Receptor, Endothelin B | 2 | 2003 | 5 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 71 | 0.070 |
Why?
|
| Macaca fascicularis | 2 | 2018 | 389 | 0.070 |
Why?
|
| Femoral Neoplasms | 1 | 2005 | 4 | 0.070 |
Why?
|
| Afferent Pathways | 1 | 2005 | 23 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 375 | 0.060 |
Why?
|
| Osteolysis | 1 | 2004 | 7 | 0.060 |
Why?
|
| Alendronate | 1 | 2004 | 12 | 0.060 |
Why?
|
| Receptor, Endothelin A | 1 | 2003 | 4 | 0.060 |
Why?
|
| Optic Nerve Injuries | 1 | 2003 | 2 | 0.060 |
Why?
|
| Optic Nerve | 1 | 2003 | 9 | 0.060 |
Why?
|
| Hypertrophy | 1 | 2003 | 26 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2002 | 12 | 0.050 |
Why?
|
| Pain Threshold | 2 | 2014 | 95 | 0.050 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2002 | 5 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 64 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 40 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 39 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 71 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 145 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2003 | 94 | 0.050 |
Why?
|
| Humans | 3 | 2020 | 29556 | 0.050 |
Why?
|
| Ankle | 1 | 2020 | 23 | 0.040 |
Why?
|
| Epidermis | 1 | 2020 | 25 | 0.040 |
Why?
|
| Albumins | 1 | 2020 | 39 | 0.040 |
Why?
|
| Electrodiagnosis | 1 | 2020 | 36 | 0.040 |
Why?
|
| Forearm | 1 | 2020 | 37 | 0.040 |
Why?
|
| Wrist | 1 | 2020 | 41 | 0.040 |
Why?
|
| Leg | 1 | 2020 | 57 | 0.040 |
Why?
|
| Neurons | 1 | 2002 | 395 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 22 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 489 | 0.040 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 2 | 2011 | 6 | 0.040 |
Why?
|
| Immunotoxins | 2 | 2011 | 16 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2017 | 71 | 0.040 |
Why?
|
| Cytokines | 1 | 2018 | 243 | 0.040 |
Why?
|
| Radiography | 2 | 2007 | 355 | 0.030 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2015 | 3 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2015 | 10 | 0.030 |
Why?
|
| Bombesin | 1 | 2015 | 8 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 2015 | 9 | 0.030 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2015 | 13 | 0.030 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2015 | 18 | 0.030 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Autoradiography | 1 | 2015 | 47 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 205 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1389 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 469 | 0.030 |
Why?
|
| Proton Pumps | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neurofilament Proteins | 1 | 2014 | 11 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2046 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2014 | 52 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2014 | 80 | 0.030 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2014 | 3 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 59 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 117 | 0.030 |
Why?
|
| Osteoclasts | 2 | 2004 | 22 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 214 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 247 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 455 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 248 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2015 | 423 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 643 | 0.030 |
Why?
|
| Anterior Horn Cells | 1 | 2011 | 2 | 0.030 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2011 | 5 | 0.030 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2011 | 5 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2011 | 10 | 0.030 |
Why?
|
| Tritium | 1 | 2011 | 17 | 0.030 |
Why?
|
| Atropine | 1 | 2011 | 16 | 0.030 |
Why?
|
| Synaptosomes | 1 | 2011 | 17 | 0.030 |
Why?
|
| Heart Rate | 1 | 2014 | 316 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 45 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2011 | 59 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 33 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2011 | 47 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 36 | 0.030 |
Why?
|
| Clonidine | 1 | 2011 | 60 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 833 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 813 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2124 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 9 | 0.020 |
Why?
|
| Dynorphins | 1 | 2007 | 9 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2007 | 22 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 18 | 0.020 |
Why?
|
| Femur | 1 | 2007 | 67 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2007 | 47 | 0.020 |
Why?
|
| Antibodies | 1 | 2007 | 53 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 9590 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 2006 | 12 | 0.020 |
Why?
|
| Thorax | 1 | 2006 | 27 | 0.020 |
Why?
|
| Wound Healing | 1 | 2007 | 186 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 10936 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 713 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 168 | 0.020 |
Why?
|
| Necrosis | 1 | 2004 | 53 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2004 | 174 | 0.010 |
Why?
|
| Hyperostosis | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 15 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2002 | 12 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 32 | 0.010 |
Why?
|
| Plant Proteins | 1 | 2002 | 13 | 0.010 |
Why?
|
| Cytotoxins | 1 | 2002 | 12 | 0.010 |
Why?
|
| Substance P | 1 | 2002 | 22 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 97 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 50 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 186 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 520 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 3128 | 0.010 |
Why?
|